Compare OPTX & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTX | ZTEK |
|---|---|---|
| Founded | 1981 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Blank Checks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.6M | 89.3M |
| IPO Year | N/A | N/A |
| Metric | OPTX | ZTEK |
|---|---|---|
| Price | $2.61 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.1M | 43.6K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,900,395.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $1.02 | $0.62 |
| 52 Week High | $4.51 | $1.84 |
| Indicator | OPTX | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 72.11 | 44.84 |
| Support Level | $2.16 | $0.64 |
| Resistance Level | $3.54 | $0.75 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 55.45 | 52.05 |
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.